Impact of shortening the blanking period to 8 weeks after PVI: Insights from COMPARE-CRYO using continuous rhythm monitoring
ERATs after PVI is common. The presence of ERATs in the third month after PVI was highly predictive of ablation failure, supporting the shortening of the BP to 8 weeks; however, the shorter BP reclassifies only 7 (3.4%) of patients to ablation failure instead of ablation success.
Authors
- Philipp Krisai (ORCID: https://orcid.org/0000-0002-4367-2363)
- Laurent Roten (ORCID: https://orcid.org/0000-0002-0827-1329)
- Thomas Kueffer (ORCID: https://orcid.org/0000-0003-3553-4945)
- Helge Servatius (ORCID: https://orcid.org/0000-0003-2887-8707)
- Nikola Kozhuharov (ORCID: https://orcid.org/0000-0003-2086-3690)
- Salik ur Rehman Iqbal (ORCID: https://orcid.org/0000-0001-6361-1130)
- Dik Heg (ORCID: https://orcid.org/0000-0002-8766-7945)
- Gregor Thalmann (ORCID: https://orcid.org/0000-0002-2050-6311)
- Michael Kühne (ORCID: https://orcid.org/0000-0002-2937-3711)
- Patrick Badertscher (ORCID: https://orcid.org/0000-0001-9751-0557)
- Jens Maurhofer (ORCID: https://orcid.org/0000-0003-4442-8941)
- Sven Knecht (ORCID: https://orcid.org/0000-0001-7122-021X)
- Hildegard Tanner (ORCID: https://orcid.org/0000-0001-9722-5617)
- Christian Sticherling (ORCID: https://orcid.org/0000-0001-8428-7050)
- Tobias Reichlin (ORCID: https://orcid.org/0000-0002-7197-8415)
- Corinne Jufer
- V Spahiu
Institutions
- University of Bern (CH)
- University Hospital of Bern (CH)
- University Hospital of Basel (CH)
Publication Details
- Journal
- Heart Rhythm
- Published
- 2024-12-13
- DOI
- https://doi.org/10.1016/j.hrthm.2024.12.013
- Citations
- 6
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.41
Funders
- National Science Foundation
- Pfizer
- Foundation for Cardiovascular Research
- Universität Basel
- Boston Scientific Corporation
- Freiwillige Akademische Gesellschaft
- Inselspital, Universitätsspital Bern
- Medtronic Europe
- European Commission
- European Society of Cardiology
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Schweizerische Herzstiftung
- Gottfried und Julia Bangerter-Rhyner-Stiftung
- MicroPort
- Biosense Webster
- Daiichi Sankyo Europe